Biomerica, Inc. (BMRA) NASDAQ
2.18
+0.02(+0.93%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.18
+0.02(+0.93%)
Currency In USD
| Previous Close | 2.16 |
| Open | 2.16 |
| Day High | 2.19 |
| Day Low | 2.15 |
| 52-Week High | 4.6 |
| 52-Week Low | 1.87 |
| Volume | 2,201 |
| Average Volume | 20,503 |
| Market Cap | 6.74M |
| PE | -1.35 |
| EPS | -1.61 |
| Moving Average 50 Days | 2.12 |
| Moving Average 200 Days | 2.61 |
| Change | 0.02 |
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain
GlobeNewswire Inc.
Mar 05, 2026 1:19 PM GMT
Registration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across Europe’s five largest countriesUK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great BritainA
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
GlobeNewswire Inc.
Feb 26, 2026 1:19 PM GMT
Physician Interview Now AvailableKey Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company’s peer-
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
GlobeNewswire Inc.
Feb 18, 2026 1:19 PM GMT
Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Biome